Join NASTAD on Tuesday, February 19 from 1:00-2:30 PM ET for a webinar on primary care provider training models for HCV Management.
In the era of Direct Acting Antivirals (DAAs), people can be cured with few side effects and incredibly high success rates in primary care settings. Despite the ease of treatment, we have seen numerous barriers to treatment access one of which is not having enough primary care providers who can or want to treat. Provider education and training is critical to expanding access to diagnosis and cure for HCV. This webinar will highlight models for primary care provider training for HCV management from CDC’s Test and Cure project grantees including Johns Hopkins University, the University of Chicago, and the University of Washington.
Please note that this is taking place in lieu of NASTAD’s February Hepatitis Workgroup call.
Register at: https://register.gotowebinar.com/register/1786592442572125708
*Be sure to register if you are interested in attending. A confirmation email with information on how to join the webinar will be sent to you after you register.
Speakers:
Risha Irvin, MD, MPH, Assistant Professor of Medicine, Johns Hopkins University
Andrew Aronsohn, MD, Associate Professor of Medicine, University of Chicago
John Scott, MD, MsC, Associate Professor of Allergy and Infectious Diseases, University of Washington
